U.S.-based manufacturing. No direct China sourcing – GUARANTEED!

Peptide Research Study

Peptides have become a central focus in modern longevity conversations, earning attention for their potential to support healthy aging, optimize recovery, and enhance overall vitality. As research continues to evolve, they are increasingly recognized as powerful tools in proactive, performance-driven wellness strategies.

The Science Behind Peptide Therapy: A Comprehensive Overview

Exploring the molecular mechanisms of peptide therapeutics and their role in personalized functional health protocols. This groundbreaking research examines how targeted peptide interventions can optimize cellular function and promote longevity.

ARTICLE

METABOLIC HEALTH

LONGEVITY

WEIGHT LOSS

PEPTIDES

Peptide therapies represent one of the most exciting frontiers in modern medicine. Peptides — short chains of amino acids that act as signaling molecules in the body — play essential roles in regulating metabolism, immune function, tissue repair, hormone balance, and cellular communication.
In fact, peptide therapy is not new. The first therapeutic peptide, insulin, was introduced in the 1920s and revolutionized the treatment of diabetes, fundamentally changing the course of modern medicine. Since then, peptide science has advanced dramatically, leading to the development of numerous targeted therapies used across endocrinology, cardiology, gastroenterology, and beyond.
Today, emerging peptide applications are being explored to support metabolic health, recovery and regeneration, cognitive function, immune resilience, and healthy aging. Because peptides are modeled after naturally occurring biological signals, they offer a highly specific and often well-tolerated approach to influencing physiologic processes.
As research continues to evolve, peptide-based therapies are expanding the possibilities of personalized, precision-guided care — bridging foundational medical science with innovative approaches to optimizing human health.


INJECTABLE PEPTIDE THERAPIES

Many peptide therapies are administered in injectable form, which allows for efficient absorption and precise dosing. Because peptides are naturally broken down in the digestive tract, oral delivery can significantly reduce their effectiveness. Subcutaneous injection (just beneath the skin) helps preserve peptide integrity and supports more predictable bioavailability.

Injectable administration also allows for tailored dosing strategies, enabling protocols to be adjusted over time based on individual response and health goals.
Peptides are commonly supplied in lyophilized (freeze-dried) form to preserve stability. Prior to use, they are reconstituted with sterile bacteriostatic water and gently mixed according to established preparation guidelines. Once reconstituted, most peptides are stored in a refrigerator to maintain potency and stability for the duration of their intended use period.
When handled properly and used under appropriate professional guidance, injectable peptide therapies offer a controlled and reliable method of delivery within structured clinical or research protocols.
pep_structure.avif

 

BENEFITS OF PROTOCOL PARTICIPATION

Why Join the global peptide study?

Scientific Data Collection
Enhance research quality and drive scientific progress by providing extensive data.

Innovative Solutions

Engage with cutting-edge methodologies and technologies that push the boundaries of peptide science.

Global Impact

Be part of a movement that influences peptide research practices worldwide, fostering global advancements.

Quality Improvement

Contribute to setting higher standards in peptide research, ensuring reliable and reproducible results.

How to Get Started

Follow these simple steps to start offering peptide protocols to your patients.

Getting Started

Select the peptide protocol that best fits your patient’s needs from our catalog.

Complete the secure payment process for your selected protocol package.

Fill out the required onboarding form sent to your email after purchase.

After Purchase

Sign the Use of Information Waiver included in the follow-up email.

Begin using the protocol with your patients following the included guidelines.

Join the scheduled medical professional sessions for ongoing follow-ups and support.

Shop Peptides

  • PROTOCOL (1)PROTOCOL IRetatrutide is a once-weekly, subcutaneous, triple-hormone receptor agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes., The protocol typically involves a gradual titration schedule, starting at low doses (e.g., 0.5–2 mg) and escalating every 4 weeks to 8–12 mg to minimize gastrointestinal side effects.This kit includes all components to support a 30-day research protocol for Retatrutide, including:1 vial of BAC water, 1 vial of Retatrutide (10mg), 2 reconstitution needles (100 units), 6 alcohol swabs, 6 injection needles (30 units), Information cardEnroll
  • PROTOCOL (3)PROTOCOL IIISemax is a synthetic heptapeptide (Met – Glu – His - Phe – Gly – Pro) derived from the N-terminal fragment of adrenocortico- tropic hormone (ACTH 4-10), specifically designed for neuroprotective, nootropic, and cognitive enhancement applicationsThis kit includes all components to support a 30-day research protocol for Semax, including:1 vial of BAC water, 1 vial of Semax (30mg), 2 reconstitution needles (100 units), 35 alcohol swabs, 35 injection needles (30 units), Information cardEnroll
attention_blue.png

 Research Use Disclaimer

 The peptide protocols referenced on this website are offered exclusively within the context of an Institutional Review Board (IRB)–approved research study. These protocols are investigational in nature and are not approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of any disease unless otherwise specifically indicated.

Participation in any research protocol is voluntary and subject to eligibility review, informed consent, and oversight in accordance with established research and ethical guidelines. Information provided on this website is intended for educational purposes only and should not be interpreted as medical advice or as a substitute for consultation with a qualified healthcare professional.

Peptides discussed herein are utilized solely within structured research protocols designed to evaluate safety, tolerability, and/or physiologic response. Individual results may vary, and no guarantees of outcomes are made or implied. 

 Services provided in connection with research participation may include telehealth-supported screening, study coordination, and ongoing research-related monitoring. Telehealth interactions are conducted for research facilitation purposes and do not replace comprehensive medical care or establish a traditional physician–patient relationship outside the defined scope of the study. If you have questions about your personal health, medical conditions, or current treatments, please consult your licensed healthcare provider. 

Dr. Sarah Franklin

Research Scientist & Associate Professor University of Utah

Dr. Sarah Franklin is a research scientist at the University of Utah, where she leads investigations at the intersection of biochemistry and cardiac physiology. She earned her degrees in biochemistry and went on to complete advanced training in cardiac physiology, giving her a unique perspective on how molecular biology translates into whole-body health.

Her research background focuses on how cellular pathways and molecular signals shape cardiovascular health and aging. This scientific foundation also informs her broader interest in how emerging therapies—such as peptides—may influence wellness, recovery, and performance.

With over 1,000 peer-reviewed citations, Dr. Franklin has established herself as a world-renowned scientist whose groundbreaking work has impacted the global scientific community. Her journey has taken her from research laboratories to humanitarian missions in war zones, always driven by a commitment to improve lives through innovative healthcare solutions.

Dr. Franklin brings both scientific expertise and a passion for making complex biology accessible and engaging. At AregoRX, she combines rigorous research with compassionate care to help patients achieve their optimal health goals through personalized peptide therapy protocols.

Credentials

B.S. Brigham Young University

Ph.D. Brigham Young University

References (Selected Publications)

Warren J, Tracy CM, Miller MR, Makaju A, Szulik MW, Yuzyuk TN, Barton DW, Wang L, García J, Sabry AD, Cawley K, Cox J, Yong Hwan Han, Boudina S, Fiehn O, Tucker H, Zaitsev AV, Franklin S. (2018) Histone Methyltransferase Smyd1 Regulates Mitochondrial Energetics in the Heart. PNAS, 115 (33): E7871-E7880. PMID: 30061404.

AregoRX Protocols are provided by NexGen Cellular Peptide, a US based certified research facility.

About NexGen Cellular Peptide
At NexGen Cellular Peptide, we are guided by a multidisciplinary team of physicians, scientists, and dedicated support professionals who are committed to advancing responsible peptide research.

Our medical and scientific team brings together clinical expertise, biomedical research experience, and a deep understanding of peptide biology. From protocol implementation to participant oversight, we work collaboratively to ensure that every research protocol is intentionally designed and ethically supported.

Equally important is our participant support team. From onboarding through ongoing study engagement, we are here to provide clear communication, education, and structured research-related support. Our goal is to ensure that every individual participating in a NexGen protocol feels informed and supported throughout the process.

We believe peptide research should be conducted with scientific rigor, transparency, and appropriate oversight. NexGen Cellular Peptide exists to support the structured utilization of peptide protocols within approved research frameworks — prioritizing safety, data integrity, and responsible advancement of the field.

Together, our physicians, scientists, and support staff form a unified team dedicated to elevating the standards of peptide research and helping move the science forward responsibly.

Credentials

B.S. Brigham Young University

Ph.D. Brigham Young University

References (Selected Publications)

Warren J, Tracy CM, Miller MR, Makaju A, Szulik MW, Yuzyuk TN, Barton DW, Wang L, García J, Sabry AD, Cawley K, Cox J, Yong Hwan Han, Boudina S, Fiehn O, Tucker H, Zaitsev AV, Franklin S. (2018) Histone Methyltransferase Smyd1 Regulates Mitochondrial Energetics in the Heart. PNAS, 115 (33): E7871-E7880. PMID: 30061404.

YOUR CART
  • No products in the cart.